Publication
Addition of cetuximab to first-line chemotherapy in patients with advanced non-small-cell lung cancer: a cost–utility analysis
Journal Paper/Review - Jan 1, 2012
Jörger Markus, Matter-Walstra K, Früh Martin
Units
Contact
Citation
Jörger M, Matter-Walstra K, Früh M. Addition of cetuximab to first-line chemotherapy in patients with advanced non-small-cell lung cancer: a cost–utility analysis. Ann Oncol 2012; 22:567-574.
Type
Journal Paper/Review (Deutsch)
Journal
Ann Oncol 2012; 22
Publication Date
Jan 1, 2012
Pages
567-574